Both in Pharmaceuticals
Longeveron vs Acurx Pharmaceuticals
Over the past year LGVN returned −80.8% and ACXP returned −83.0%; their daily moves had a correlation of 0.06.
LGVN −80.8% ACXP −83.0%Growth of $1, one year, split-adjusted
| Metric | LGVN | ACXP |
|---|---|---|
| Price | $1.78 | $1.07 |
| Market cap | $5.7M | $5.9M |
| Today | +2.89% | +0.94% |
| 1 month | −34.6% | −18.0% |
| 6 months | −79.4% | −45.7% |
| Year to date | −64.8% | −57.0% |
| 1 year | −80.6% | −83.8% |
| Revenue growth (YoY) | −9.2% | — |
| Gross margin | 63.4% | — |
| Net margin | −2116.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 4.8× | — |
| Net cash | $10.1M | $10.7M |
| Dividend yield | — | — |
| Volatility (60d) | 708.8% | 60.4% |
| Short % of float | 2.8% | 1.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).